Thane, India

Parag Lokhande

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Ferring B.v.. Active years: 2021-2024.

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 4.3

ph-index = 1


Location History:

  • Thane-Maharashtra, IN (2021)
  • Maharashtra, IN (2023 - 2024)

Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Parag Lokhande: Innovator in Pharmaceutical Formulations

Introduction

Parag Lokhande is a notable inventor based in Thane, Maharashtra, India. He has made significant contributions to the field of pharmaceutical formulations, holding a total of 3 patents. His work focuses on creating innovative solutions that enhance the effectiveness of pharmaceutical products.

Latest Patents

Parag Lokhande's latest patents include a free-flowing solid pharmaceutical formulation that comprises one or more active ingredients along with a blend of sorbitol and liquid paraffin. This formulation is designed to improve the delivery and efficacy of medications. Additionally, he has developed a package containing this formulation, a process for its manufacture, and the use of the blend in the formulation.

Career Highlights

Parag is currently associated with Ferring B.V., a company known for its commitment to advancing healthcare through innovative pharmaceutical solutions. His role at Ferring B.V. allows him to apply his expertise in developing cutting-edge formulations that meet the needs of patients and healthcare providers.

Collaborations

Throughout his career, Parag has collaborated with talented professionals, including Ganeshchandra Sonavane and Pradeep Sethi. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical innovations.

Conclusion

Parag Lokhande's contributions to pharmaceutical formulations exemplify his dedication to innovation in healthcare. His patents reflect a commitment to improving patient outcomes through effective and efficient pharmaceutical solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…